Trade Signals — 2026-08-19

Generated daily from AI analysis. Individual reports saved next to this file.

BAC: 30/100 - Overbought near $65.23 resistance with fading momentum; no earnings risk but no clean entry or R:R edge.

JPM: 28/100 - Bullish daily trend but ADX 16.7 signals ranging; sub-2:1 R:R to nearest stop below $360.96.

MA: 25/100 - Mixed consolidation at 81% of 10-day range near $578.50; insufficient reward-to-risk for either direction.

XOM: 24/100 - Overbought RSI 72.4 at immediate $165.67 resistance; poor R:R despite intact uptrend.

HEATINGOIL: 55/100 - Bullish trend and geopolitical supply support, but weak volume (RVOL 0.10x) and overbought stochRSI near $4.49 resistance.

PFE: 62/100 - Confirmed breakout above $27.40 with clean 2:1 R:R and no earnings risk; below-average volume slightly weakens confirmation.

MRK: 30/100 - Long-term uptrend but sub-1:1 R:R at $137.98 resistance with extremely overbought StochRSI; no clean entry.

JNJ: 70/100 - Strong +3.3% breakout on above-average volume within uptrend; 2:1 R:R at structure with no earnings risk; only minor 1H overbought concern.

COCOA: 25/100 - Wide ATR (286) and proximity to $6,100 resistance make 2R targets impractical; low-volume up-move lacks conviction.

CORN: 22/100 - Overbought 5.7% gap on 0.19x volume at $491.15 resistance; weekly USDA reports add headline gap risk.

Overall winner: JNJ - 70/100 - cleanest trend-aligned, volume-confirmed setup with proper 2:1 structure and zero earnings exposure inside the window.

BAC

Confidence: 75/100

Key Levels

  • Resistance: $65.23, $64.27
  • Support: $62.39, $60.71, $58.67

Rationale

No acceptable setup. BAC is trading at 64.23, only ~1.6% below major resistance at 65.23, while daily momentum is fading (MACD histogram negative, StochRSI K/D 40.44/54.46) and weekly RSI is overbought at 73.6. A long entry near resistance offers poor reward-to-risk to the nearest meaningful target, below the required 2:1. A short is not justified because price remains above key moving averages and the daily trend is still defined as mixed/consolidating with a rising Supertrend. Better entries would be a breakout above 65.23 or a pullback toward 62.39/60.71. Next earnings on 2026-10-14 is outside the 10-day holding window, so gap risk is not a concern.

Risks

  • Weekly RSI at 73.6 indicates overbought conditions; a pullback could occur before further upside.
  • Price is within 1.6% of strong resistance at 65.23, capping near-term upside.
  • Daily MACD histogram is falling, suggesting momentum may be rolling over despite the strong trend.
  • Financial sector rotation or macro shocks could cause a sharp reversal near the 52-week high.

News Summary

Verified next earnings date is 2026-10-14, outside the 10-day holding window. Recent news: BAC announced Asia Pacific investment banking leadership changes; the stock has broken above and successfully retested $57 resistance and remains in an uptrend; analyst price targets range from $61 to $75. Sources: TradingView, Barchart, Tickzen.


{
  "ticker": "BAC",
  "direction": "NO_TRADE",
  "entry_price": null,
  "stop_loss": null,
  "take_profit_1": null,
  "take_profit_2": null,
  "reward_risk_ratio": null,
  "position_size_pct": null,
  "confidence": 75,
  "holding_period_days": null,
  "key_levels": {
    "support": [
      62.39,
      60.71,
      58.67
    ],
    "resistance": [
      65.23,
      64.27
    ]
  },
  "rationale": "No acceptable setup. BAC is trading at 64.23, only ~1.6% below major resistance at 65.23, while daily momentum is fading (MACD histogram negative, StochRSI K/D 40.44/54.46) and weekly RSI is overbought at 73.6. A long entry near resistance offers poor reward-to-risk to the nearest meaningful target, below the required 2:1. A short is not justified because price remains above key moving averages and the daily trend is still defined as mixed/consolidating with a rising Supertrend. Better entries would be a breakout above 65.23 or a pullback toward 62.39/60.71. Next earnings on 2026-10-14 is outside the 10-day holding window, so gap risk is not a concern.",
  "risks": [
    "Weekly RSI at 73.6 indicates overbought conditions; a pullback could occur before further upside.",
    "Price is within 1.6% of strong resistance at 65.23, capping near-term upside.",
    "Daily MACD histogram is falling, suggesting momentum may be rolling over despite the strong trend.",
    "Financial sector rotation or macro shocks could cause a sharp reversal near the 52-week high."
  ],
  "news_summary": "Verified next earnings date is 2026-10-14, outside the 10-day holding window. Recent news: BAC announced Asia Pacific investment banking leadership changes; the stock has broken above and successfully retested $57 resistance and remains in an uptrend; analyst price targets range from $61 to $75. Sources: TradingView, Barchart, Tickzen."
}

JPM

Confidence: 20/100

Key Levels

  • Resistance: $366.50, $373.90
  • Support: $353.33, $356.50, $360.96

Rationale

Daily trend is bullish (price above 200 SMA, EMAs aligned, Supertrend up), but price is trading just below the 366.50 resistance (52-week high) with mixed momentum: ADX 16.7 (ranging), MACD histogram negative, RSI 64.4 neutral, and several oscillators (StochRSI, Williams %R) flashing selling pressure. Web search confirms overbought signals (weekly RSI 73.2, CCI overbought) and expectations of consolidation in a range. Nearest structural support is 360.96 (recent swing low), only 2.29 below current price, which is less than 1x ATR (6.09). Using the required tightened stop at 360.96 would give a reward:risk of only 1.42:1 to the 366.50 resistance (below the 2:1 minimum). A wider stop would violate the tighten-to-nearest-structure rule. No confirmed reversal pattern exists to justify a short against the bullish trend. Therefore, no trade meets the risk-reward criteria.

Risks

  • Breakout above 366.50 could trigger a rally and create a missed long opportunity.
  • Overbought conditions could lead to a sharp pullback if support breaks.
  • Earnings are outside the holding window, but unexpected geopolitical or macro news could still cause gap moves.

News Summary

JPM reported strong Q2 2026 results (net income up to $21.2B, +41% YoY) and continues robust capital returns with higher dividends and buybacks (businesswire.com, yahoo.com). Technical analysis from fxempire.com and tradersunion.com notes the stock is near resistance with overbought signals (RSI ~64, CCI >100) and a likely rangebound move between $356.5 and $366.5. Next earnings date is 2026-10-13, outside the 10-day holding window, so earnings gap risk is low.


{
  "ticker": "JPM",
  "direction": "NO_TRADE",
  "entry_price": null,
  "stop_loss": null,
  "take_profit_1": null,
  "take_profit_2": null,
  "reward_risk_ratio": null,
  "position_size_pct": null,
  "confidence": 20,
  "holding_period_days": null,
  "key_levels": {
    "support": [
      353.33,
      356.5,
      360.96
    ],
    "resistance": [
      366.5,
      373.9
    ]
  },
  "rationale": "Daily trend is bullish (price above 200 SMA, EMAs aligned, Supertrend up), but price is trading just below the 366.50 resistance (52-week high) with mixed momentum: ADX 16.7 (ranging), MACD histogram negative, RSI 64.4 neutral, and several oscillators (StochRSI, Williams %R) flashing selling pressure. Web search confirms overbought signals (weekly RSI 73.2, CCI overbought) and expectations of consolidation in a range. Nearest structural support is 360.96 (recent swing low), only 2.29 below current price, which is less than 1x ATR (6.09). Using the required tightened stop at 360.96 would give a reward:risk of only 1.42:1 to the 366.50 resistance (below the 2:1 minimum). A wider stop would violate the tighten-to-nearest-structure rule. No confirmed reversal pattern exists to justify a short against the bullish trend. Therefore, no trade meets the risk-reward criteria.",
  "risks": [
    "Breakout above 366.50 could trigger a rally and create a missed long opportunity.",
    "Overbought conditions could lead to a sharp pullback if support breaks.",
    "Earnings are outside the holding window, but unexpected geopolitical or macro news could still cause gap moves."
  ],
  "news_summary": "JPM reported strong Q2 2026 results (net income up to $21.2B, +41% YoY) and continues robust capital returns with higher dividends and buybacks ([businesswire.com](https://www.businesswire.com), [yahoo.com](https://finance.yahoo.com)). Technical analysis from [fxempire.com](https://www.fxempire.com/stocks/jpm/technical-analysis) and [tradersunion.com](https://tradersunion.com/news/stocks/show/3012088-jpmorgan-chase-up-0-13percent-this/) notes the stock is near resistance with overbought signals (RSI ~64, CCI >100) and a likely rangebound move between $356.5 and $366.5. Next earnings date is 2026-10-13, outside the 10-day holding window, so earnings gap risk is low."
}

MA

Confidence: 30/100

Key Levels

  • Resistance: $578.50, $583.71
  • Support: $556.06, $523.61, $463.74

Rationale

Daily trend is mixed/consolidating, price at 81% of 10-day range near resistance 578.50. Long entry offers insufficient reward:risk (target beyond 52w high). Short goes against bullish macro and lacks confirmed reversal setup. No MA-specific news found; next earnings on 2026-10-29 is outside window. Therefore no acceptable setup.

Risks

  • Resistance at 578.50 could cap upside
  • Low VIX may signal complacency and sharp pullback risk
  • Market macro bullish per SPY, but potential correction per snpedge

News Summary

Technical analysis of SPY shows bullish golden cross and MACD positive (AltIndex), but weekend review notes limited support and a possible pullback to fill inefficiencies (snpedge). No specific Mastercard news was found in the search results.


{
  "ticker": "MA",
  "direction": "NO_TRADE",
  "entry_price": null,
  "stop_loss": null,
  "take_profit_1": null,
  "take_profit_2": null,
  "reward_risk_ratio": null,
  "position_size_pct": null,
  "confidence": 30,
  "holding_period_days": null,
  "key_levels": {
    "support": [
      556.06,
      523.61,
      463.74
    ],
    "resistance": [
      578.5,
      583.71
    ]
  },
  "rationale": "Daily trend is mixed/consolidating, price at 81% of 10-day range near resistance 578.50. Long entry offers insufficient reward:risk (target beyond 52w high). Short goes against bullish macro and lacks confirmed reversal setup. No MA-specific news found; next earnings on 2026-10-29 is outside window. Therefore no acceptable setup.",
  "risks": [
    "Resistance at 578.50 could cap upside",
    "Low VIX may signal complacency and sharp pullback risk",
    "Market macro bullish per SPY, but potential correction per [snpedge](https://snpedge.vicitradingsolutions.com/p/s-and-p-500-weekend-review-one-buy)"
  ],
  "news_summary": "Technical analysis of SPY shows bullish golden cross and MACD positive ([AltIndex](https://altindex.com/ticker/spy/technical-analysis)), but weekend review notes limited support and a possible pullback to fill inefficiencies ([snpedge](https://snpedge.vicitradingsolutions.com/p/s-and-p-500-weekend-review-one-buy)). No specific Mastercard news was found in the search results."
}

XOM

Confidence: 15/100

Key Levels

  • Resistance: $165.67, $174.09, $176.50
  • Support: $157.43, $150.18, $148.13

Rationale

Price is at immediate resistance (165.67) with daily RSI at 72.4 (overbought) and Bollinger %B above 1.0. A long entry here offers poor reward:risk (nearest structural stop would be ~1.5x ATR at 160.08, only ~3.3% risk for minimal upside before major resistance). No confirmed reversal signal exists for a short, and the daily trend remains bullish/consolidating. Waiting for a pullback to support or a confirmed breakout above 165.67 with volume would provide a better setup. Earnings are 72+ days away, so no gap risk, but current technicals are stretched.

Risks

  • Overbought RSI and price above upper Bollinger Band increase pullback risk
  • Resistance at 165.67 could cap upside without a strong catalyst
  • Recent sharp 8.6% rally in 7 sessions may lead to profit-taking
  • Oil price volatility could affect the stock

News Summary

ExxonMobil beat revenue expectations in Q2 2026, with adjusted EPS of $3.52 (slightly below estimates). The company returned $9.4B to shareholders, reduced net debt, and achieved record Permian production. Awarded $1.1B in pre-investment contracts for Rovuma LNG Phase 1. Analysts remain bullish (consensus Buy), with price targets ranging from $142 to $177. Next earnings on 10/30/26, outside the 10-day window.


{
  "ticker": "XOM",
  "direction": "NO_TRADE",
  "entry_price": null,
  "stop_loss": null,
  "take_profit_1": null,
  "take_profit_2": null,
  "reward_risk_ratio": null,
  "position_size_pct": null,
  "confidence": 15,
  "holding_period_days": null,
  "key_levels": {
    "support": [
      157.43,
      150.18,
      148.13
    ],
    "resistance": [
      165.67,
      174.09,
      176.5
    ]
  },
  "rationale": "Price is at immediate resistance (165.67) with daily RSI at 72.4 (overbought) and Bollinger %B above 1.0. A long entry here offers poor reward:risk (nearest structural stop would be ~1.5x ATR at 160.08, only ~3.3% risk for minimal upside before major resistance). No confirmed reversal signal exists for a short, and the daily trend remains bullish/consolidating. Waiting for a pullback to support or a confirmed breakout above 165.67 with volume would provide a better setup. Earnings are 72+ days away, so no gap risk, but current technicals are stretched.",
  "risks": [
    "Overbought RSI and price above upper Bollinger Band increase pullback risk",
    "Resistance at 165.67 could cap upside without a strong catalyst",
    "Recent sharp 8.6% rally in 7 sessions may lead to profit-taking",
    "Oil price volatility could affect the stock"
  ],
  "news_summary": "ExxonMobil beat revenue expectations in Q2 2026, with adjusted EPS of $3.52 (slightly below estimates). The company returned $9.4B to shareholders, reduced net debt, and achieved record Permian production. Awarded $1.1B in pre-investment contracts for Rovuma LNG Phase 1. Analysts remain bullish (consensus Buy), with price targets ranging from $142 to $177. Next earnings on 10/30/26, outside the 10-day window."
}

HEATINGOIL BUY

Direction: BUY
Entry: $4.37 (limit)
Stop Loss: $4.24
Take Profit 1: $4.63 (+5.9%)
Take Profit 2: $4.84 (+10.8%)
R:R: 2.0
Position Size: 1.0% of account
Confidence: 65/100
Holding Period: 10 days

Key Levels

  • Resistance: $4.49, $4.84
  • Support: $4.25, $3.73, $3.67

Rationale

Daily trend is bullish (price above 200 SMA, 9/21/50 EMAs, Supertrend UP, ADX 30). Fundamentals remain supportive: Middle East tensions and Hormuz shipping disruptions (FXEmpire) plus Goldman's bullish oil outlook to $120. Price sits at 83% of 10-day range, near resistance at 4.49; a breakout could extend to 4.84 (52w high). Entry at current price with stop below 4.25 swing low (structural) at 4.24. TP1 at 4.63 (2R) and TP2 at 4.84. No earnings risk as futures contract. Sources: fxempire.com, fxempire.com

Risks

  • Geopolitical tensions could ease abruptly, triggering sharp oil selloff
  • IEA forecasts a significant drop in global oil demand in 2026
  • Price already near strong resistance at 4.49; may stall or reverse
  • Low volume on last bar (RVOL 0.10x) indicates weak participation
  • StochRSI overbought (K 87.75) may precede a pullback

News Summary

Heating oil futures trading around $4.37; geopolitical risks (Strait of Hormuz shipping disruptions, Iran tensions) support oil prices. Goldman Sachs predicts oil could reach $120 amid simultaneous crises. Demand outlook mixed: IEA sees demand drop, OPEC remains optimistic. fxempire.com, fxempire.com, barrons.com


{
  "ticker": "HO=F",
  "direction": "LONG",
  "entry_price": 4.37,
  "stop_loss": 4.24,
  "take_profit_1": 4.63,
  "take_profit_2": 4.84,
  "reward_risk_ratio": 2.0,
  "position_size_pct": 1.0,
  "confidence": 65,
  "holding_period_days": 10,
  "key_levels": {
    "support": [
      4.25,
      3.73,
      3.67
    ],
    "resistance": [
      4.49,
      4.84
    ]
  },
  "rationale": "Daily trend is bullish (price above 200 SMA, 9/21/50 EMAs, Supertrend UP, ADX 30). Fundamentals remain supportive: Middle East tensions and Hormuz shipping disruptions (FXEmpire) plus Goldman's bullish oil outlook to $120. Price sits at 83% of 10-day range, near resistance at 4.49; a breakout could extend to 4.84 (52w high). Entry at current price with stop below 4.25 swing low (structural) at 4.24. TP1 at 4.63 (2R) and TP2 at 4.84. No earnings risk as futures contract. Sources: [fxempire.com](https://www.fxempire.com/forecasts/article/crude-oil-price-forecast-iran-tensions-push-brent-toward-100-1617321), [fxempire.com](https://www.fxempire.com/forecasts/article/natural-gas-and-oil-forecast-wti-holds-81-as-hormuz-shipping-risks-intensify-1617100)",
  "risks": [
    "Geopolitical tensions could ease abruptly, triggering sharp oil selloff",
    "IEA forecasts a significant drop in global oil demand in 2026",
    "Price already near strong resistance at 4.49; may stall or reverse",
    "Low volume on last bar (RVOL 0.10x) indicates weak participation",
    "StochRSI overbought (K 87.75) may precede a pullback"
  ],
  "news_summary": "Heating oil futures trading around $4.37; geopolitical risks (Strait of Hormuz shipping disruptions, Iran tensions) support oil prices. Goldman Sachs predicts oil could reach $120 amid simultaneous crises. Demand outlook mixed: IEA sees demand drop, OPEC remains optimistic. [fxempire.com](https://www.fxempire.com/forecasts/article/crude-oil-price-forecast-iran-tensions-push-brent-toward-100-1617321), [fxempire.com](https://www.fxempire.com/forecasts/article/natural-gas-and-oil-forecast-wti-holds-81-as-hormuz-shipping-risks-intensify-1617100), [barrons.com](https://www.barrons.com/market-data/futures/ho00)"
}

PFE BUY

Direction: BUY
Entry: $27.45 (limit)
Stop Loss: $26.95
Take Profit 1: $28.45 (+3.6%)
Take Profit 2: $28.95 (+5.5%)
R:R: 2.0
Position Size: 1.0% of account
Confidence: 60/100
Holding Period: 10 days

Key Levels

  • Resistance: $27.40, $27.80, $28.45
  • Support: $26.80, $26.30, $25.30

Rationale

Long on confirmed breakout above 27.40 resistance. Daily momentum is constructive: price is above EMA 9/21/50 and 200-day SMA, Supertrend is UP, ADX 35.8, MACD histogram rising, CMF 0.26 showing accumulation. Q2 EPS/Revenue beat and raised FY guidance provide fundamental tailwind. Next earnings is Nov 3, 2026, outside the 10-day holding window, so gap risk is low. Stop at 26.95 sits below 26.80 structural support; TP1 at 28.45 provides a 2:1 reward/risk ratio, with TP2 extended to 28.95.

Risks

  • Daily RSI at 71.1 and price near the upper Bollinger Band could lead to an overbought pullback
  • Failure to break and hold above 27.40 could keep the stock range-bound
  • Below-average volume (RVOL 0.88) may reduce breakout conviction
  • Pharma regulatory or legal headlines may cause overnight gaps

News Summary

Q2 2026 EPS beat at $0.77 vs $0.68 est, revenue $15.03B vs $14.40B est; company raised full-year revenue guidance and reaffirmed dividend commitment (tradingview.com). The stock has rallied from roughly $25 to $27.25 on improving short-term momentum, though longer-term trend confirmation still requires a move above key resistance (cryptonomist.ch). Next earnings is scheduled for Nov 3, 2026, outside the 10-day holding window.


{
  "ticker": "PFE",
  "direction": "LONG",
  "entry_price": 27.45,
  "stop_loss": 26.95,
  "take_profit_1": 28.45,
  "take_profit_2": 28.95,
  "reward_risk_ratio": 2.0,
  "position_size_pct": 1.0,
  "confidence": 60,
  "holding_period_days": 10,
  "key_levels": {
    "support": [
      26.8,
      26.3,
      25.3
    ],
    "resistance": [
      27.4,
      27.8,
      28.45
    ]
  },
  "rationale": "Long on confirmed breakout above 27.40 resistance. Daily momentum is constructive: price is above EMA 9/21/50 and 200-day SMA, Supertrend is UP, ADX 35.8, MACD histogram rising, CMF 0.26 showing accumulation. Q2 EPS/Revenue beat and raised FY guidance provide fundamental tailwind. Next earnings is Nov 3, 2026, outside the 10-day holding window, so gap risk is low. Stop at 26.95 sits below 26.80 structural support; TP1 at 28.45 provides a 2:1 reward/risk ratio, with TP2 extended to 28.95.",
  "risks": [
    "Daily RSI at 71.1 and price near the upper Bollinger Band could lead to an overbought pullback",
    "Failure to break and hold above 27.40 could keep the stock range-bound",
    "Below-average volume (RVOL 0.88) may reduce breakout conviction",
    "Pharma regulatory or legal headlines may cause overnight gaps"
  ],
  "news_summary": "Q2 2026 EPS beat at $0.77 vs $0.68 est, revenue $15.03B vs $14.40B est; company raised full-year revenue guidance and reaffirmed dividend commitment ([tradingview.com](https://www.tradingview.com/symbols/NYSE-PFE/)). The stock has rallied from roughly $25 to $27.25 on improving short-term momentum, though longer-term trend confirmation still requires a move above key resistance ([cryptonomist.ch](https://en.cryptonomist.ch/2026/08/04/pfizer-pfe-stock-tests-25-33-resistance-after-guidance-hike/)). Next earnings is scheduled for Nov 3, 2026, outside the 10-day holding window."
}

MRK

Confidence: 85/100

Key Levels

  • Resistance: $137.98, $139.86
  • Support: $126.68, $126.22, $133.28

Rationale

Long-term trend is up, but the immediate setup is poor: price is near the 10d/20d/60d resistance at 137.98, only ~2.1% above current price, while a reasonable stop would need to be at least 1.5x ATR (~4.9 points) away, producing a reward/risk ratio below 1:1. Short-term momentum is fading (last session closed -0.6% on above-average volume, 1H price below VWAP, StochRSI extremely overbought at 93.67/97.89). Web-based technical analysis also indicates no decent entry and recommends waiting for consolidation (chartmill.com, tradingdashboard.com). A short is not justified because the daily trend remains up and no confirmed reversal signal (trendline reclaim + volume + RSI divergence) exists. Earnings are confirmed 71 days away, so gap risk is low, but the lack of a favorable risk/reward makes this a NO_TRADE.

Risks

  • Resistance at 137.98 cap upside; long entry would have negative reward/risk
  • StochRSI and stochastic are in extreme overbought territory, increasing pullback risk
  • Momentum is mixed with MACD histogram declining and 1H price below VWAP
  • No confirmed reversal setup exists to justify shorting in the uptrend

News Summary

Web search confirmed next earnings date is 2026-10-29, outside the 10-day holding window (barchart.com). Recent Q2 earnings were released on 2026-08-04, and the stock has rallied strongly over the past month (+~6% in 1 month, +~20% in 3 months). Technical sources rate the long-term trend bullish but note overbought short-term conditions and a lack of a clean entry, with Barchart giving a 100% Buy while Chartmill rates the setup only 3/10 and recommends waiting for consolidation.


{
  "ticker": "MRK",
  "direction": "NO_TRADE",
  "entry_price": null,
  "stop_loss": null,
  "take_profit_1": null,
  "take_profit_2": null,
  "reward_risk_ratio": null,
  "position_size_pct": null,
  "confidence": 85,
  "holding_period_days": null,
  "key_levels": {
    "support": [
      126.68,
      126.22,
      133.28
    ],
    "resistance": [
      137.98,
      139.86
    ]
  },
  "rationale": "Long-term trend is up, but the immediate setup is poor: price is near the 10d/20d/60d resistance at 137.98, only ~2.1% above current price, while a reasonable stop would need to be at least 1.5x ATR (~4.9 points) away, producing a reward/risk ratio below 1:1. Short-term momentum is fading (last session closed -0.6% on above-average volume, 1H price below VWAP, StochRSI extremely overbought at 93.67/97.89). Web-based technical analysis also indicates no decent entry and recommends waiting for consolidation ([chartmill.com](https://www.chartmill.com/stock/quote/MRK/technical-analysis), [tradingdashboard.com](https://tradingdashboard.com/en/stocks/MRK-NYSE)). A short is not justified because the daily trend remains up and no confirmed reversal signal (trendline reclaim + volume + RSI divergence) exists. Earnings are confirmed 71 days away, so gap risk is low, but the lack of a favorable risk/reward makes this a NO_TRADE.",
  "risks": [
    "Resistance at 137.98 cap upside; long entry would have negative reward/risk",
    "StochRSI and stochastic are in extreme overbought territory, increasing pullback risk",
    "Momentum is mixed with MACD histogram declining and 1H price below VWAP",
    "No confirmed reversal setup exists to justify shorting in the uptrend"
  ],
  "news_summary": "Web search confirmed next earnings date is 2026-10-29, outside the 10-day holding window ([barchart.com](https://www.barchart.com/stocks/quotes/mrk)). Recent Q2 earnings were released on 2026-08-04, and the stock has rallied strongly over the past month (+~6% in 1 month, +~20% in 3 months). Technical sources rate the long-term trend bullish but note overbought short-term conditions and a lack of a clean entry, with Barchart giving a 100% Buy while Chartmill rates the setup only 3/10 and recommends waiting for consolidation."
}

JNJ BUY

Direction: BUY
Entry: $271.11 (limit)
Stop Loss: $266.11
Take Profit 1: $281.11 (+3.7%)
Take Profit 2: $291.11 (+7.4%)
R:R: 2.0
Position Size: 2.0% of account
Confidence: 65/100
Holding Period: 10 days

Key Levels

  • Resistance: $274.90, $271.73
  • Support: $267.50, $262.40, $254.50

Rationale

JNJ is in a clear longer-term uptrend, trading above all key SMAs (200, 50, 21, 9) and the Supertrend is up. The stock broke out sharply on 2026-08-18 (+3.3%) on above-average volume, pushing above the consolidation range. Daily RSI is 66.7 (not overbought), MACD is rising, and CMF shows strong accumulation. The nearest resistance is the 52-week high at 274.90, a break of which could trigger a sustained move. Entry at current price provides a tight stop below the 8/18 gap fill support (267.5) and the 1H VWAP structure. The reward:risk to the first target is 2:1, and the second target offers 4:1. No earnings risk within the 10-day window (next earnings 2026-10-13).

Risks

  • Overbought short-term (1H RSI 76.6, price above upper Bollinger Band) could lead to a pullback before further upside.
  • Failure to break above the 52-week high at 274.90 may result in sideways consolidation or a sharp reversal.
  • High position in the 10-day range (96%) suggests limited immediate upside without a consolidation.
  • Healthcare sector news or macro events could cause unexpected volatility.

News Summary

Web search confirms next earnings on 2026-10-13 (outside holding window). JNJ is trading above its 200- and 50-day SMAs with a Moderate Buy analyst consensus, and will present at the Morgan Stanley Global Healthcare Conference on 2026-09-14. No negative catalysts found; the stock is in a strong uptrend with supportive fundamentals.


{
  "ticker": "JNJ",
  "direction": "LONG",
  "entry_price": 271.11,
  "stop_loss": 266.11,
  "take_profit_1": 281.11,
  "take_profit_2": 291.11,
  "reward_risk_ratio": 2.0,
  "position_size_pct": 2.0,
  "confidence": 65,
  "holding_period_days": 10,
  "key_levels": {
    "support": [
      267.5,
      262.4,
      254.5
    ],
    "resistance": [
      274.9,
      271.73
    ]
  },
  "rationale": "JNJ is in a clear longer-term uptrend, trading above all key SMAs (200, 50, 21, 9) and the Supertrend is up. The stock broke out sharply on 2026-08-18 (+3.3%) on above-average volume, pushing above the consolidation range. Daily RSI is 66.7 (not overbought), MACD is rising, and CMF shows strong accumulation. The nearest resistance is the 52-week high at 274.90, a break of which could trigger a sustained move. Entry at current price provides a tight stop below the 8/18 gap fill support (267.5) and the 1H VWAP structure. The reward:risk to the first target is 2:1, and the second target offers 4:1. No earnings risk within the 10-day window (next earnings 2026-10-13).",
  "risks": [
    "Overbought short-term (1H RSI 76.6, price above upper Bollinger Band) could lead to a pullback before further upside.",
    "Failure to break above the 52-week high at 274.90 may result in sideways consolidation or a sharp reversal.",
    "High position in the 10-day range (96%) suggests limited immediate upside without a consolidation.",
    "Healthcare sector news or macro events could cause unexpected volatility."
  ],
  "news_summary": "Web search confirms next earnings on 2026-10-13 (outside holding window). JNJ is trading above its 200- and 50-day SMAs with a Moderate Buy analyst consensus, and will present at the Morgan Stanley Global Healthcare Conference on 2026-09-14. No negative catalysts found; the stock is in a strong uptrend with supportive fundamentals."
}

COCOA

Confidence: 75/100

Key Levels

  • Resistance: $6,100.00, $6,222.00, $6,309.00
  • Support: $5,425.00, $4,992.00, $3,694.00

Rationale

Daily trend is mixed but with a bullish bias: price sits above the 200 SMA, all EMAs, Supertrend is UP, MACD positive, and CMF shows accumulation. However, price is near the top of a 10-day range with immediate resistance at 6100 and a wide daily ATR of 286. A long from current levels would require a stop 1.0-1.5x ATR below, putting the first 2R target above 6300-6497, beyond substantial resistance. No confirmed breakout and no pullback to a support level exist for a favorable entry. The 1-hour VWAP/RSI provide no edge, and volume on the recent up-move was weak. Web search returned no relevant cocoa news for CC=F (results referenced NYSE:CC Chemours), confirming no imminent catalyst. Thus, no acceptable risk/reward setup is available.

Risks

  • High daily ATR (~4.8%) creates wide stop distances and makes a 2:1 reward-to-risk target impractical near resistance.
  • Immediate resistance at 6100-6222-6309 caps upside potential within the 10-day window.
  • Recent up-move on August 17 occurred on low volume (RVOL 0.47x), suggesting weak conviction.
  • Potential false breakout if price tops above 6100 without sustained buying.
  • No confirmed reversal setup to justify a short against the prevailing bullish bias.

News Summary

Web search returned no news specific to CC=F (cocoa futures). The results provided pertained to NYSE:CC (Chemours), which reported Q2 earnings on Aug 4, next earnings Oct 28/Nov 5, with a securities fraud investigation and analyst price target raises. No schedule-relevant catalyst for CC=F was found.


{
  "ticker": "CC=F",
  "direction": "NO_TRADE",
  "entry_price": null,
  "stop_loss": null,
  "take_profit_1": null,
  "take_profit_2": null,
  "reward_risk_ratio": null,
  "position_size_pct": null,
  "confidence": 75,
  "holding_period_days": null,
  "key_levels": {
    "support": [
      5425,
      4992,
      3694
    ],
    "resistance": [
      6100,
      6222,
      6309
    ]
  },
  "rationale": "Daily trend is mixed but with a bullish bias: price sits above the 200 SMA, all EMAs, Supertrend is UP, MACD positive, and CMF shows accumulation. However, price is near the top of a 10-day range with immediate resistance at 6100 and a wide daily ATR of 286. A long from current levels would require a stop 1.0-1.5x ATR below, putting the first 2R target above 6300-6497, beyond substantial resistance. No confirmed breakout and no pullback to a support level exist for a favorable entry. The 1-hour VWAP/RSI provide no edge, and volume on the recent up-move was weak. Web search returned no relevant cocoa news for CC=F (results referenced NYSE:CC Chemours), confirming no imminent catalyst. Thus, no acceptable risk/reward setup is available.",
  "risks": [
    "High daily ATR (~4.8%) creates wide stop distances and makes a 2:1 reward-to-risk target impractical near resistance.",
    "Immediate resistance at 6100-6222-6309 caps upside potential within the 10-day window.",
    "Recent up-move on August 17 occurred on low volume (RVOL 0.47x), suggesting weak conviction.",
    "Potential false breakout if price tops above 6100 without sustained buying.",
    "No confirmed reversal setup to justify a short against the prevailing bullish bias."
  ],
  "news_summary": "Web search returned no news specific to CC=F (cocoa futures). The results provided pertained to NYSE:CC (Chemours), which reported Q2 earnings on Aug 4, next earnings Oct 28/Nov 5, with a securities fraud investigation and analyst price target raises. No schedule-relevant catalyst for CC=F was found."
}

CORN

Confidence: 30/100

Key Levels

  • Resistance: $491.00, $491.15
  • Support: $478.85, $434.00

Rationale

Price is pressing against the 491.00/491.15 resistance zone after a massive 5.7% gap on extremely low volume (RVOL 0.19x). Daily RSI is overbought at 70.2, Bollinger %B above 1, and StochRSI near 97, indicating an overextended move. OBV is falling and CMF is negative, suggesting distribution. ADX 18.8 reflects a ranging/consolidating market, not a strong trend. A long entry near resistance offers poor reward:risk (stop below 478.85 would require a target of ~512, unrealistic without historical reference). A short entry lacks a confirmed reversal setup (no bearish divergence or trendline break) and would counter the prevailing uptrend. With no scheduled USDA report inside the 10-day window but weekly Crop Progress reports adding headline risk, no acceptable setup meets the 2:1 reward:risk and stop-loss criteria.

Risks

  • Breakout above 491.15 on strong volume could lead to a rapid advance, but entry here would be chasing an overbought move.
  • Low volume on the gap suggests a possible gap-and-fade, yet shorting against the daily uptrend is not justified without confirmation.
  • Weekly Crop Progress reports (Mondays) can trigger sharp intraday moves.
  • Macro or weather headlines could cause unexpected gaps, invalidating technical levels.

News Summary

Corn futures are near the upper end of their forecast volatility band (478.85–491.15) per tradersunion.com, with price holding above key moving averages and momentum bullish. nexusfi.com warns that USDA report days can cause limit moves that gap through stops, though the next major WASDE is likely in September, outside the 10-day horizon. lpfutures.com emphasizes the volatility around USDA and weather events. No earnings date applies to futures.


{
  "ticker": "ZC=F",
  "direction": "NO_TRADE",
  "entry_price": null,
  "stop_loss": null,
  "take_profit_1": null,
  "take_profit_2": null,
  "reward_risk_ratio": null,
  "position_size_pct": null,
  "confidence": 30,
  "holding_period_days": null,
  "key_levels": {
    "support": [
      478.85,
      434.0
    ],
    "resistance": [
      491.0,
      491.15
    ]
  },
  "rationale": "Price is pressing against the 491.00/491.15 resistance zone after a massive 5.7% gap on extremely low volume (RVOL 0.19x). Daily RSI is overbought at 70.2, Bollinger %B above 1, and StochRSI near 97, indicating an overextended move. OBV is falling and CMF is negative, suggesting distribution. ADX 18.8 reflects a ranging/consolidating market, not a strong trend. A long entry near resistance offers poor reward:risk (stop below 478.85 would require a target of ~512, unrealistic without historical reference). A short entry lacks a confirmed reversal setup (no bearish divergence or trendline break) and would counter the prevailing uptrend. With no scheduled USDA report inside the 10-day window but weekly Crop Progress reports adding headline risk, no acceptable setup meets the 2:1 reward:risk and stop-loss criteria.",
  "risks": [
    "Breakout above 491.15 on strong volume could lead to a rapid advance, but entry here would be chasing an overbought move.",
    "Low volume on the gap suggests a possible gap-and-fade, yet shorting against the daily uptrend is not justified without confirmation.",
    "Weekly Crop Progress reports (Mondays) can trigger sharp intraday moves.",
    "Macro or weather headlines could cause unexpected gaps, invalidating technical levels."
  ],
  "news_summary": "Corn futures are near the upper end of their forecast volatility band (478.85–491.15) per [tradersunion.com](https://tradersunion.com/news/commodities/show/3011634-corn-futures-edge-up-0-05percent/), with price holding above key moving averages and momentum bullish. [nexusfi.com](https://nexusfi.com/a/instruments/corn-futures-zc) warns that USDA report days can cause limit moves that gap through stops, though the next major WASDE is likely in September, outside the 10-day horizon. [lpfutures.com](https://lpfutures.com/grains/) emphasizes the volatility around USDA and weather events. No earnings date applies to futures."
}